Amaç: Bu çalışmanın amacı tekrarlayan ve/veya tedaviye dirençli vajinit öyküsü olan olgularda vajinal yıkama sıvısı C-reaktif protein (CRP) düzeylerinin değerlendirilmesidir.
INTRODUCTION
Vulvovaginal inflammation is identified as vulvovaginitis with symptoms such as leucorrhea, pruritus, soreness, dysuria and dyspareunia. The etiologic factors of vulvovaginitis are infectious, irritant, allergic, hormonal, iatrogenic, traumatic and dermatoses [1] . Bacterial vaginosis (BV), vulvovaginal candidiasis, and Trichomonas vaginalis are the most common causes of infectious vulvovaginitis and streptococcus, staphylococcus, and human immunodeficiency virus (HIV) are rare causes of vaginitis [2] . Bacterial vaginosis is the most common among these vaginal disorders. Vaginal douching (VD) is a common habit in women and is performed for personal hygiene or other aesthetic reasons. It is reported to be a frequent cause of BV and treatment resistant vaginitis especially in patients with lower socioeconomic status [3, 4] . Tissue injury, infection and inflammation increase acute phase proteins. Creactive protein (CRP) is an acute phase protein [5] . Previous studies evaluated inflammatory cytokines in vaginal washing fluid [6, 7] .
In current study, we aimed to determine the vaginal washing fluid's (VWF) CRP level in women with a history of recurrent and treatment-resistant vaginitis and association between demographic and clinical parameters.
METHODS
This prospective case-controlled study was conducted in the Zekai Tahir Burak Women's Health Education and Research Hospital, which is a referral tertiary hospital located in Ankara, Turkey. A total of 64 married women were recruited from gynecology outpatient clinic between May 2013 and July 2013. Thirty three of the patients who had a history of recurrent and treatment-resistant vaginitis constituted the study group, whereas 31 healthy women constituted the control group. Patients applied to our outpatient clinic for periodical routine examination or due to recurrent vaginal discharge. None of the patients in the study had clinically acute vaginitis during the pelvic examination. Each participant gave written informed consent by the time of sample collection and the study was approved by the hospital's local ethics committee.
The main parameters recorded for each woman were; age, parity, detailed medical history, educational level, socioeconomic status and frequency of VD. Participants were required to be at least three days past the end of the most recent menstruation, most recent unprotected penile-vaginal intercourse and most recent VD. They were also required to be at least three weeks past the most recent use of local or systemic anti-infective agents. Recurrent infection was defined as four or more occurrences of symptomatic vulvovaginitis in the past year whereas treatment resistant vulvovaginitis was defined as at least once occurrence consecutive symptomatic vulvovaginitis despite adequate treatment in the past year. The patients with acute and chronic infections, rheumatic and other inflammatory diseases, malignancy, tissue injury and necrosis, and cardiovascular diseases were excluded from the study. All of the patients were examined on dorsolithotomy position after a detailed sexual and medical history was obtained. During the vaginal exam a sterile speculum was introduced into the vagina to see the cervix, and fresh culture samples were taken from the cervix and vagina. After the fresh culture sample had been taken, 5 ml sterile saline solution was injected into the vagina and aspirated from the posterior fornix with the same syringe. The procedure was completed with a bimanual pelvic examination. The VWF sample was centrifuged at 3000 rpm for 10 minutes and was analyzed immediately. In this study we used an enzyme-linked immunosorbent assay to determine the levels of CRP in vaginal washing fluid. The patients with positive vaginal culture were excluded from the study.
Statistical analysis
Continuous variables were calculated by the mean and standard deviation. Independent sample t-test was performed to evaluate associations both continuous variables. Receiver operator characteristics curve (ROC) analysis was performed to find out the predictive role of vaginal washing fluid CRP levels in study group. The sample size was determined according to the results of the central limit theorem, which indicated that we needed at least 30 individuals in each subgroup [8] . Two-sided p values were assumed statistically significant when p < 0.05. Statistical analyses were performed using the SPSS software (ver. 17.0 for Windows; SPSS, Chicago, IL, USA).
RESULTS
The mean age of the patients was 31.8±7.4. The median (minimum-maximum) parity of the patients was 2 (0-9). The cases were divided into two groups according to having a history of recurrent and treatment resistant vaginitis (study group, n=33) or not (control group, n=31). son of these groups. The mean age and parity of the groups were similar (p>0.05). The initial symptoms were also showed no difference between the groups. The white blood cell levels in blood and urine was statistically significantly higher in study group (p<0.05). The mean vaginal washing fluid CRP levels were also significantly higher in the study group (p=0.023). The subsequent analysis were performed to evaluate the vaginal washing fluid CRP levels in patients who had VD or not and having lower socioeconomic status and educational level or not (Table  2) . Patients who had more than three VD had statistically higher VWF CRP levels (0.012). Patients with lower socioeconomic status and educational level also had higher VWF CRP levels (p<0.05).
ROC curve analysis demonstrated that VWF CRP levels may be a discriminative factor in recurrent and treatment resistant vaginitis with an area under the curve (AUC) of 0.65 (Figure 1 ). When the cut-off point for the CRP level was set to 0.125, the sensitivity and specificity levels were found to be 72.7% and 74.2%, respectively. 
DISCUSSION
The main finding of the current study is that VWF CRP level is higher in patients with a history of recurrent and treatment resistant vulvovaginitis. It suggests that these patients may be inclined to give local immunological reactions. The risk factors of this condition are VD and lower socioeconomic status and educational level. Vaginal douching with water, soap, or chemical products is a common practice among women worldwide, especially those of lower socioeconomic status. The main causes of vaginal douching are genital hygiene and religious beliefs. Several studies have shown that VD disturbs the normal vaginal flora and increases the risk of vulvovaginitis [9, 10] . Guzel et al [3] reported that vaginal douching is a common practice among women, especially those of lower educational and socioeconomic status. The frequency of VD was found to be the most important risk factors for these adverse effects including treatment resistant vulvovaginitis and pelvic inflammatory disease. The literature search showed that VD is associated with different etiologic agents including candidiasis, trichomoniasis or BV [10] [11] [12] .
Klebanoff et al [13] found that the symptoms of vaginitis were vaginal discharge, odor, and wetness. Eckert et al [14] reported that vaginitis, especially candidiasis, mostly presents as vaginal itching and burning. Recurrent vulvovaginal candidiasis is a common cause of vaginal discharge, affecting over 50% of all women at least once in their life. In 5-10% of these women, this infection is recurring [15] .
Trichomonas vaginalis is sexually transmitted disease that can be associated with cervicitis and urethritis beside vaginitis. Recurrence and treatment resistance is common in women infected with Trichomonas vaginalis [16] .
BV is one of the most common causes of vaginal discharge in reproductive age women. A polimicrobial etiology probably is responsible. However, Schwebke et al [17] suggested that BV is initiated by sexually transmission of Gardnerella vaginalis. BV is associated with significant clinical consequences. There is an increased risk of HIV acquisition, preterm delivery and pelvic inflammatory disease in women with this infection [18] [19] [20] . A recent meta-analysis demonstrated that oral contraceptive use reduces the development of BV [21] .
CRP is an acute phase protein which rises in response to inflammation. Its physiologic role is to activate the complement system, and to facilitate phagocytosis. The increase of the CRP occurs as a result of a rise in the concentration of interleukin 6, which is produced by macrophages as well as adipocytes in response to a wide range of acute and chronic inflammatory conditions [5] . These inflammatory conditions cause release of interleukin 6 and other cytokines that trigger the synthesis of CRP and fibrinogen by the liver. CRP plays an important role in innate immunity as an early defense system against infections, and it is used mainly as a marker of inflammation [22] .
Recent studies have focused on determining the importance of vaginal-associated immunity. The published literature search suggests that recurrent candidiasis is associated with a localized vaginal allergic response [23] . And it was also shown that patients with recurrent candidiasis had impairment in candida specific cellular immunity and over active neutrophil response [24, 25] . Weissenbacher et al [26] found that some cytokines related to allergic response to the candida species was statistically significantly higher in vaginal fluid of women with recurrent vulvovaginal candidiasis. Lev-Sagie et al [27] reported that hyaluronan, a complex carbohydrate related to immune system, concentrations in vaginal lavage fluid were elevated significantly in women with a current acute recurrent vulvovaginal candidiasis. These patients also may have a polymorphism in the genes coding for antimicrobial proteins and anti-inflammatory cytokines such as mannose binding lectin and interleukin 4 [28, 29] . Although the pathophysiology of recurrent vulvovaginitis to be continued to investigate, the main reason is still not explained.
To the best of our knowledge, this is the first study evaluating VWF CRP level in women with a history of recurrent or treatment resistant vulvovaginitis. The findings of this study are somewhat limited by certain aspects of the study design. Our sample size was also limited, and the findings must be verified in larger populations. And, although VWF CRP levels were statistically significantly higher in the study group, all results were in normal reference range in both groups.
In conclusion, according to this study we found that patients with lower socioeconomic status and educational level had more treatment resistant and recurrent vaginitis. VD frequency was also higher in this group and we think that related to these conditions VWF CRP levels were higher in these patients. Therefore this marker may be used to determine the patients who will develop recurrence and treatment resistant vulvovaginitis in advance. Larger and further studies are required to evaluate the predictive value of VWF CRP levels in recurrent and treatment resistant vulvovaginitis.
